Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06812234 · ClinicalTrials.gov registry record · NA
Impact of Digital Ambient EXperience on Pediatric Subspecialist Documentation Burden
A NA study, sponsored by Children's Healthcare of Atlanta.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT06812234: Completed NA study, sponsored by Children's Healthcare of Atlanta.
NCT06812234 is a NA study that has completed, run by Children's Healthcare of Atlanta. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06812234, a NA study, has completed, sponsored by Children's Healthcare of Atlanta.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This randomized quality improvement pilot project aims to assess whether the implementation of generative AI software for documentation, Microsoft Nuance's Digital Ambient eXperience (DAX) Copilot, enhances physician documentation efficiency and reduces burnout.
Primary Outcome
Per Epic Signal: Average number of minutes per scheduled day spent in charting activities outside 7 AM to 5:30 PM on weekdays, time outside scheduled hours on weekends, and time on unscheduled holidays. Numerator: Minutes spent in charting activities outside 7 AM to 5:30 PM on weekdays and outside scheduled hours on weekends. Denominator: Scheduled days where time was spent in the system within the reporting period.
Interventions
- OTHER DAX Copilot
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2024-08-01 |
| Phase | NA |
What the finished NCT06812234 record still lists
NCT06812234 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which DAX Copilot is the first listed.
NCT06812234 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06812234 about?
NCT06812234 is a clinical study titled "Impact of Digital Ambient EXperience on Pediatric Subspecialist Documentation Burden". This randomized quality improvement pilot project aims to assess whether the implementation of generative AI software for documentation, Microsoft Nuance's Digital Ambient eXperience (DAX) Copilot, enhances physician documentation efficiency and reduces burnout.
What is the current status of trial NCT06812234?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2024-05-01. Estimated completion is 2024-08-01.
What interventions are being tested in trial NCT06812234?
The interventions under investigation include: DAX Copilot (OTHER).
Who is sponsoring clinical trial NCT06812234?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06812234's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI